Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04109443 · ClinicalTrials.gov registry record · NA
Young Men and Media Study
A NA study, sponsored by Boston University.
- Completed
- Registry status
- NA
- Development phase
- 154
- Enrollment target
NCT04109443 is a NA study that has completed, run by Boston University. The registered enrollment target is 154 participants.
The verdict
NCT04109443, a NA study, has completed, sponsored by Boston University.
- COMPLETED
- Registry status
- NA
- Development phase
- 154 participants
- Enrollment target
Study Summary
Adolescent sexual minority males (ASMM) continue to account for a disproportionate number of HIV infections in the United States. Racial and ethnic minority populations are particularly affected. Increased HIV rates reflect sexual risk behaviors during early sexual experiences. Research suggests that initial sexual risk-taking occurs during adolescence among sexual minority males. Therefore, it is important for HIV prevention interventions to target adolescent sexual minority males. Targeting sexual minority males during adolescence will help them learn and establish healthy sexual behaviors early in their psychosexual development, which will have both immediate and long-term health benefits.To promote adolescent sexual minority males' critical examination of online media and decrease their sexual risk-taking, this study proposes an exploratory clinical trial to pilot test an online sexual health media literacy intervention that was developed during formative research for feasibility and acceptability. Overall, the proposed research has the potential to reach a wide audience of sexual minority males early in their sexual development, ultimately decreasing their sexual risk-taking and reducing the number of new HIV infections in this population.
Interventions
- BEHAVIORAL Young Men & Media Program
- BEHAVIORAL Available websites on safe sex and preventing STIs
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 154 participants |
| Start Date | 2020-03-27 |
| Est. Completion | 2020-08-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04109443
The ClinicalTrials.gov registry entry for NCT04109443 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 154 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston University, which has 185 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Young Men & Media Program is the first listed.
NCT04109443 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04109443 about?
NCT04109443 is a clinical study titled "Young Men and Media Study". Adolescent sexual minority males (ASMM) continue to account for a disproportionate number of HIV infections in the United States. Racial and ethnic minority populations are particularly affected. Increased HIV rates reflect sexual risk behaviors during early sexual experiences. Research suggests tha...
What is the current status of trial NCT04109443?
This trial is currently completed. It is a NA study. The enrollment target is 154 participants. The study started on 2020-03-27. Estimated completion is 2020-08-17.
What interventions are being tested in trial NCT04109443?
The interventions under investigation include: Young Men & Media Program (BEHAVIORAL), Available websites on safe sex and preventing STIs (BEHAVIORAL).
Who is sponsoring clinical trial NCT04109443?
This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.